Description
Imbruvica (ibrutinib) is an oral prescription medication that acts as a kinase inhibitor to help treat certain blood cancers. Available as tablets (140mg, 230mg, 420mg, 560mg), capsules (70mg, 140mg), and suspension (70mg/mL), it's manufactured by Pharmacyclics LLC. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Ibrutinib | HTML | Access the FDA dataset for Ibrutinib — ANDA 205552 submitted by Mylan Institutional LLC | Open resource |